Semaglutide is not strongly linked to yeast infections the way some other diabetes medications are. In clinical comparisons, people taking GLP-1 receptor agonists like semaglutide had a 0.7% rate of genital tract infections over one year, compared to 2.0% for those on SGLT2 inhibitors like empagliflozin or dapagliflozin. That said, yeast infections do still occur in some people on semaglutide, and there are several plausible reasons why.
How Semaglutide May Shift Vaginal Health
Semaglutide works by mimicking a gut hormone called GLP-1, which slows digestion, reduces appetite, and lowers blood sugar. These effects ripple through several body systems in ways that can indirectly create conditions favorable to yeast overgrowth.
The gut microbiome is one pathway. GLP-1 medications alter how quickly food moves through your digestive tract and can change the balance of bacteria living there. Your gut microbiome and vaginal microbiome are closely connected. When gut bacteria shift, the vaginal environment can follow, potentially reducing the protective bacteria (lactobacilli) that keep yeast in check. This can make infections like bacterial vaginosis or vaginal candidiasis more likely.
Rapid weight loss is another factor. Semaglutide often produces significant fat loss, and fat tissue stores estrogen. As fat decreases, circulating estrogen levels can drop. Lower estrogen thins the vaginal lining and changes its pH, which can weaken the vaginal ecosystem’s natural defenses against yeast. This mechanism is similar to what happens during menopause, when declining estrogen makes yeast infections more common.
Blood Sugar Swings and Immune Effects
If you’re taking semaglutide for type 2 diabetes, the underlying condition itself is a major risk factor for yeast infections. Elevated blood sugar feeds Candida, the fungus responsible for most yeast infections. Semaglutide lowers blood sugar, which should be protective over time. But during the adjustment period, blood sugar levels can fluctuate more than usual, and any episodes of higher glucose create an opportunity for yeast to thrive.
There’s also an immune dimension. GLP-1 receptor agonists have anti-inflammatory properties, which is generally beneficial. But the immune system relies on controlled inflammation to fight off fungal overgrowth. Some researchers have speculated that the immune-modulating effects of GLP-1 drugs could, in certain individuals, slightly reduce the body’s vigilance against opportunistic organisms like Candida. This remains a theoretical mechanism rather than a well-documented one.
Semaglutide vs. Other Diabetes Medications
It’s worth putting this in perspective. SGLT2 inhibitors, a different class of diabetes drug, cause yeast infections at nearly three times the rate of GLP-1 medications like semaglutide. A large study published in Diabetes Care found that SGLT2 inhibitor users had a genital tract infection rate of 2.0% in the first year, compared to just 0.7% for GLP-1 receptor agonist users. The reason is straightforward: SGLT2 inhibitors work by flushing excess sugar out through urine, creating a sugar-rich environment in the urinary and genital tract that yeast loves. Semaglutide does not work this way.
So if you switched from an SGLT2 inhibitor to semaglutide and are still getting yeast infections, the lingering infections may be related to other factors rather than the semaglutide itself. And if you started semaglutide and developed a yeast infection for the first time, the medication’s effects on your microbiome, weight, and hormones are more likely contributors than a direct pharmacological cause.
What Makes Some People More Susceptible
Not everyone on semaglutide will experience yeast infections. Several factors raise your individual risk:
- Speed of weight loss. Losing weight rapidly creates bigger hormonal shifts. People who lose a large percentage of body weight in a short time may notice more vaginal symptoms than those who lose weight gradually.
- Antibiotic use. If you take antibiotics while on semaglutide, you’re hitting your microbiome from two directions. Antibiotics wipe out protective bacteria, and semaglutide’s digestive changes may slow their recovery.
- Diet changes. Many people on semaglutide eat significantly less and change what they eat. A diet very low in fiber or fermented foods can reduce beneficial gut bacteria, which in turn affects vaginal flora.
- Dehydration. Semaglutide’s common side effects include nausea, vomiting, and reduced appetite, all of which can lead to lower fluid intake. Dehydration concentrates urine and changes the moisture balance of mucous membranes, creating conditions where yeast can take hold.
Reducing Your Risk
Staying well-hydrated is one of the simplest protective steps, especially during the first few months when nausea tends to be worst. Probiotic-rich foods like yogurt, kefir, or fermented vegetables support both gut and vaginal bacterial populations. Wearing breathable cotton underwear and avoiding prolonged time in damp clothing helps keep the external environment less hospitable to yeast.
If you’re getting recurrent yeast infections after starting semaglutide, tracking when they occur relative to dose changes or weight milestones can help identify the trigger. Some people find that infections cluster during periods of rapid weight loss and taper off once weight stabilizes. Over-the-counter antifungal treatments work the same way they would for any yeast infection, and the infections themselves are not a sign that semaglutide is harmful or needs to be stopped.